An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection

计划入组 239 人 · 首次发布于 2015 年 11 月 5 日

Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection

计划入组 68 人 · 首次发布于 2014 年 4 月 29 日

Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations

计划入组 10 人 · 首次发布于 2012 年 1 月 25 日

Glecaprevir(Maviret, Mavyret)

C₃₈H₄₆F₄N₆O₉S

Grazoprevir(Zepatier)

C₃₈H₅₀N₆O₉S

Simeprevir

C₃₈H₄₇N₅O₇S₂ · Rx

Quince Therapeutics

United States

KalVista Pharmaceuticals

United States

TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.

China

Health Canada Approves MAVIRET as First Eight-Week Treatment for Acute Hepatitis C

Hepatitis C Pricing Wars of 2014 Offer Blueprint for Current GLP-1 Obesity Drug Competition

IRBM Develops Novel Allosteric Inhibitor Targeting Zika Virus Protease with Broad Flavivirus Potential